Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1.363,50 GBX | +0,59% | +2,71% | +1,26% |
21/01 | Zwitserse biofarmaceut BioVersys plant beursgang in eerste kwartaal | RE |
21/01 | GSK's Jemperli krijgt uitgebreide goedkeuring van Europese Commissie | MT |
Toevoegen aan een lijst 0 geselecteerde | Dividendrendement | Dividendrendement | K/w-verhouding | Koers-boekwaarde | EV/omzet | Beurskap. / EBITDA | Beurskap. / EBIT | Kapi. ($) | |
---|---|---|---|---|---|---|---|---|---|
+4.45% | +4.75% | 15.99x | 3.75x | 2.22x | 6.91x | 7.69x | 68,12 mld. | ||
+0.69% | +0.79% | 60.02x | 40.16x | 15.48x | 43.29x | 48.67x | 679 mld. | ||
+1.88% | +2.40% | 26.01x | 18.35x | 9.23x | 18.62x | 20.96x | 360 mld. | ||
+3.28% | +3.45% | 20.98x | 4.91x | 4.07x | 11.87x | 13.39x | 350 mld. | ||
+3.68% | +3.86% | 36.51x | 39.2x | 6.38x | 14.05x | 14.52x | 299 mld. | ||
+3.59% | +3.69% | 16.5x | 6.12x | 3.88x | 10.13x | 11.31x | 242 mld. | ||
+3.19% | +3.35% | 13.58x | 5.14x | 4.13x | 9.87x | 11.07x | 242 mld. | ||
+2.28% | +2.42% | 25.5x | 5.1x | 4.38x | 13.8x | 13.69x | 211 mld. | ||
+3.80% | +3.92% | 17.78x | 4.49x | 4.2x | 10.69x | 11.16x | 198 mld. | ||
+6.41% | +6.53% | 14.81x | 1.66x | 3.26x | 8.28x | 9.99x | 147 mld. | ||
+3.30% | +3.52% | 29.94x | 22.6x | 5.92x | 10.42x | 13.26x | 147 mld. | ||
+3.91% | +4.17% | 16.8x | 1.63x | 2.95x | 9.88x | 10.69x | 128 mld. | ||
+3.29% | +3.47% | 894.79x | 6.11x | 4.74x | 12.74x | 16.28x | 116 mld. | ||
+4.18% | +4.30% | -18.42x | 6.74x | 3.23x | 27.86x | 32.49x | 116 mld. | ||
+1.34% | +1.46% | 28.17x | 5.84x | 8.67x | 17.53x | 18.92x | 69,51 mld. | ||
+1.37% | +1.64% | 37.37x | 5.02x | 4.16x | 22.56x | 28.97x | 53,73 mld. | ||
+1.67% | +1.92% | 22.63x | 2x | 3.69x | 14.82x | 16.47x | 41,41 mld. | ||
+4.85% | +5.00% | 53.26x | 0.89x | 2.35x | 9.89x | 33.26x | 40,9 mld. | ||
+0.53% | +0.58% | 46.97x | 6.26x | 9.54x | 37.48x | 39.79x | 38,86 mld. | ||
Gemiddelde | +3,04% | +3,22% | 71,53x | 9,79x | 5,39x | 16,35x | 19,61x | 186,75 mld. | |
Gewogen gemiddelde per kap. | +2,77% | +2,96% | 57,75x | 16,50x | 7,08x | 19,29x | 21,86x |
- Beurs
- Aandelen
- Koers GSK
- Sector GSK plc
- Sectorale dividenden